维普期刊资源整合服务平台（V6.5）

112篇 您的检索式：作者名="Solit"

选中清除导出查看参考文献查看引证文献引用追踪共6页首页上一页第1页下一页末页 /6 跳转

	题名	作者	年代	出处	被引量
1	Pulsatile administration of the epidermal growth factor receptor inhibitor gefitinib is significantly more effective than continuous dosing for sentitizing tumors to paclitaxel显示文摘	Solit DB She Y Lobe J	2005	clin cancer Res2005，11，：	1
2	Development and application of Hsp90 inhibitors显示文摘	Solit D B Chiosis G	2008	Drug Discov Today2008，13，12：	1
3	New Efficient Synthesis of ResorcJnylic Macrolides via Ynolides: Establishment of Cycloproparadicicol as Synthetically Feasible Preclinical Anticancer Agent Based on Hsp90 as the Target 显示文摘	YANG Z GENG X SOLIT D	2004	J Am Chem Soc2004，126，：	1
4	KRAS and BRAF: drug targets and pre- dictive biomarkers显示文摘	Vakiani E Solit D B	2011	J Pathol2011，223，2：	1
5	In- hibition of heart shock protein in 90 function down-regulates Akt kinase and sensitizes tumors to taxol显示文摘	Solit DB Basso AD Olshen AB	2003	Cancer Res2003，62，9：	1
6	HsP90:a novel target for cancer therapy显示文摘	Solit DB Rosen N	2006	Curr Top Med Chem2006，6，11：	1
7	BRAF mutation predicts sensitivity to MEK inhibition 显示文摘	Solit DB Garraway LA Pratilas CA	2006	Nature2006，439，7074：	1
8	Akt forms an intracellular comJplex with heat shock Protein 90 (HSP90) and Cdc37 andis destabilized by Inhibitors of HSP90 funCtion 显示文摘	Basso AD Solit DB Chiosis G	2002	Biol Chem2002，277，39：	1
9	KRAS and BRAF:drug targets and predictive biomarkers显示文摘	Vakiani E Solit DB		0，，02：	1
10	Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol显示文摘	Solit D B Basso A D Olshen A B	2003	Cancer Res2003，63，9：	1
11	Development and application oi Hsp90 inhibitors显示文摘	Solit DB Chiosis G	2008	Drug Discov Today2008，13，12：	1
12	Modulation of Hsp90 function by ansamycins sensitizes breast cance cells to chemotherapy-induced apoptosis in an RB-and schedule-dependent manner 显示文摘	Munster PN Basso A Solit D	2001	Clin Cancer Res2001，7，：	1
13	BRAF mutation predicts sensitivity to MEK inhibition 显示文摘	SOLIT D B GARRAWAY L A PRATILAS C A	2005	Nature2005，439，7074：	1
14	Inhibition of heat shock protein 90 function downregulatesAkt kinase and sensitizes tumors to Taxol 显示文摘	Solit DB Basso AD Olshen AB	2003	Cancer Res2003，63，：	1
15	A phase Ⅰ trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors显示文摘	Fury MG Solit DB Su YB	2007	Cancer Chemother Pharmacol2007，59，：	1
16	Inhi- bition of heat shock protein 90 function down-regu- lates Akt kinase and sensitizes rumors to taxol 显示文摘	SOLIT D B BASSO A D OLSHEN A B	2003	Cancer Res2003，63，9：	1
17	KRAS and BRAF: drug targets and predictive biomarkers 显示文摘	Vakiani E Solit DB	2011	J Pathol2011，223，2：	1
18	Inhibition of heat shock protein 90 function down-regnlates Akt kinase and sensitizes tumors to Taxol显示文摘	Basso AD Olshen AB	2003	Cancer Res2003，63，9：	1
19	T he BAD protein integrates survival signaling by egfr/mapk and PI 3 K/akt kinase pathways in pten-deficient tumor ceils 显示文摘	She QB Solit DB Ye Q	2005	Cancer Cell2005，8，4：	1
20	Angiosperm phylogeny inferred from 18s rDNA,rbcL and atpB sequences显示文摘	Solits DE Solits PS Chase MW 2000	2000	Bot J Linn Soc2000，133，：	1

返回顶部每页显示：

共6页首页上一页第1页下一页末页 /6 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示